# Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease

> **NCT06962891** · — · ACTIVE_NOT_RECRUITING · sponsor: **Angel Argiles** · enrollment: 213 (estimated)

## Conditions studied

- Chronic Kidney Disease(CKD)
- Progression, Disease

## Interventions

- **DIAGNOSTIC_TEST:** CKD progression biomarker

## Key facts

- **NCT ID:** NCT06962891
- **Lead sponsor:** Angel Argiles
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-02
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06962891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06962891, "Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06962891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*